These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8792417)

  • 1. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.
    Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):820-31. PubMed ID: 8792417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of drug delivery systems for macromolecular drugs].
    Takakura Y
    Yakugaku Zasshi; 1996 Jul; 116(7):519-32. PubMed ID: 8831257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations for targeted drug delivery.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2013 Jan; 65(1):139-47. PubMed ID: 23280371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of gene drug delivery systems based on pharmacokinetic studies.
    Takakura Y; Nishikawa M; Yamashita F; Hashida M
    Eur J Pharm Sci; 2001 Apr; 13(1):71-6. PubMed ID: 11292570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of targeted delivery systems for nucleic acid drugs.
    Mahato RI; Takakura Y; Hashida M
    J Drug Target; 1997; 4(6):337-57. PubMed ID: 9239575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview.
    Hashida M
    Adv Drug Deliv Rev; 2020; 157():71-82. PubMed ID: 32565225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential properties of drug-targeting delivery systems.
    Petrak K
    Drug Discov Today; 2005 Dec; 10(23-24):1667-73. PubMed ID: 16376827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges to macromolecular drug delivery.
    Juliano R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo.
    Wang L; Prakash RK; Stein CA; Koehn RK; Ruffner DE
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):169-89. PubMed ID: 12954117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic considerations in gene therapy.
    Kamiya H; Akita H; Harashima H
    Drug Discov Today; 2003 Nov; 8(21):990-6. PubMed ID: 14643162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.
    Glassman PM; Muzykantov VR
    J Pharmacol Exp Ther; 2019 Sep; 370(3):570-580. PubMed ID: 30837281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug delivery systems in gene therapy].
    Takakura Y
    Nihon Rinsho; 1998 Mar; 56(3):691-5. PubMed ID: 9549358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of glycosylated carriers for drug delivery.
    Jain K; Kesharwani P; Gupta U; Jain NK
    Biomaterials; 2012 Jun; 33(16):4166-86. PubMed ID: 22398205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design strategies to improve soluble macromolecular delivery constructs.
    Christie RJ; Grainger DW
    Adv Drug Deliv Rev; 2003 Feb; 55(3):421-37. PubMed ID: 12628325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Say no to drugs: Bioactive macromolecular therapeutics without conventional drugs.
    Rütter M; Milošević N; David A
    J Control Release; 2021 Feb; 330():1191-1207. PubMed ID: 33207257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation-mediated targeting of carriers.
    Kawakami S; Hashida M
    J Control Release; 2014 Sep; 190():542-55. PubMed ID: 24915504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of intracellular drug delivery system using fusogenic liposomes].
    Yoshikawa T; Okada N; Nakagawa S
    Yakugaku Zasshi; 2007 May; 127(5):789-96. PubMed ID: 17473520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.